21 – 30 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
(
- Contribution to journal › Article
-
Mark
Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells
(
- Contribution to journal › Article
-
Mark
SHARPIN stabilizes estrogen receptor a and promotes breast cancer cell proliferation
(
- Contribution to journal › Article
-
Mark
Mitochondria chaperone GRP75 moonlighting as a cell cycle controller to derail endocytosis provides an opportunity for nanomicrosphere intracellular delivery
(
- Contribution to journal › Article
-
Mark
On the origin of myeloid-derived suppressor cells
(
- Contribution to journal › Scientific review
-
Mark
ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
(
- Contribution to journal › Article
-
Mark
Implementing liquid biopsies into clinical decision making for cancer immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
(
- Contribution to journal › Article
-
Mark
Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy
(
- Contribution to journal › Article
-
Mark
The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo
(
- Contribution to journal › Article